BUSINESS● LOWAug 28 · Aug 28, 2026, 10:48 AM
Pfizer-backed Priovant wins FDA approval for lead asset
Seeking Alpha Tech · north america
Priovant, a company supported by Pfizer, has received FDA approval for its primary product. This marks a significant regulatory milestone for the pharmaceutical asset.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS7m agoBrightSpring Health Services Non-GAAP EPS of $0.54 beats by $0.07, revenue of $4.21B beats by $340M, raises FY guidanceSeeking Alpha TechBUSINESS7m agoNaples Airport to close for the whole of November for €30m revamp – here’s what passengers need to knowEuroNews [en]